CYCLERION THERAPEUTICS, INC. Other Current Liabilities
CYCLERION THERAPEUTICS, INC. (CYCN) had Other Current Liabilities of $5.56 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2019-05-13
- 2019-03-31: Other Liabilities, Current $5.56M.
- 2018-12-31: Other Liabilities, Current $9.80M.
| Period end | Other Liabilities, Current |
|---|---|
| 2019-03-31 | $5.56M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $9.80M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |